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Fragment D (M, 100000) prepared from a terminal plasmin digest of fibrinogen was
isolated and used to study its effect on fibrin formation. Increasing amounts of fragment
D added to a solution of fibrinogen and thrombin decrease the rigidity of the resultant
gel (10% of control at 2mol of fragment D/mol of fibrinogen). Half-maximal inhibition
is achieved at 1 mol of fragment D/mol of fibrinogen for non-cross-linked clots and at
imol of fragment D/mol of fibrinogen for cross-linked clots. 'Clottability' decreases
concomitantly with the rigidity. Only small amounts of fragment D (less than 10% for
non-cross-linked gels) are incorporated into the gel. Light-scattering shows an increase
in the final fibre thickness at fragment D concentrations up to 2mol of fragment D/mol
of fibrinogen, from 60 molecules/cross-section for the control to 120 molecules/
cross-section. Higher fragment D concentrations lead to a decrease in the final fibre
thickness. The limit fibre thickness is 8 nm, with a length of 80nm, which is equivalent to
a fibrin trimer. On the basis of results of synthetic-substrate and fibrinopeptide-release
assays, it is clear that thrombin inactivation is not responsible for this effect. These data
suggest that fragment D may inhibit fibrin formation by blocking the bimolecular
polymerization of activated fibrin monomer molecules to form protofibrils, although
additional effects on subsequent assembly steps may also be involved.
Fibrinogen is the soluble plasma protein that, as a
result of proteolytic cleavage by the enzyme throm-
bin, can be converted into a solid fibrin gel, a major
component of the blood clot. Fibrinogen contains
three pairs of polypeptides, which are organized into
several functional domains. Doolittle (1977) has
reviewed the electron-microscopic, amino-acid-
sequence and physical-chemical data on fibrinogen
and proposed a model for its three-dimensional
structure in which all six N-termini are joined by
disulphide links into a central domain termed the
'N-terminal disulphide knot' ('N-DSK'). Helix pre-
diction schemes (Doolittle, 1977) indicate that the
a-, ,B- and y-chains form regions of coiled coil that
connect this central domain to two identical outer
globular domains. Although recent electron-micro-
scopic data indicate that these outer domains are
multinodular (Weisel et al., 1981), the trinodular
picture of fibrinogen serves as a useful working
model that is consistent with most of the available
data. In the blood-coagulation mechanism, fibrin
assembly is a multistep process that begins with the
activation of fibrinogen by thrombin. Thrombin first
cleaves the two A-fibrinopeptides from the Aa-
Abbreviation used: SDS, sodium dodecyl sulphate.
chains of fibrinogen (Bettelheim, 1956; Blomback,
1958; Blombaick et al., 1978) and then more slowly
the B-peptides from the B/I-chains (Blombiick,
1958). Once fibrinopeptide A has been removed,
fibrin monomer is formed and the self-assembly
process is initiated. Fibrin monomer spontaneously
polymerizes to form protofibrils in which the mono-
mers are arranged end-to-end in a half-staggered-
overlap pattern (Ferry, 1952; Casassa, 1955; Hall &
Slayter, 1959). Protofibrils rapidly combine to form
longer thicker fibres that, through branchpoint
formation, organize a three-dimensional network or
fibrin gel. The fibre size in the network is kinetically
determined, and the network is held together by
non-covalent interactions. The final step in fibrin
assembly is the stabilization of the gel through the
formation of e-(-glutamyl)-lysyl bonds to yield
cross-linked y-chain dimers and a-polymers. The
cross-linking reaction is catalysed by the trans-
glutaminase, factor XIIIa.
When coagulation is initiated in plasma, the
fibrinolytic system is also activated, and plasmino-
gen is converted into plasmin. Plasminogen acti-
vation may also occur in certain pathological states
in the absence of coagulation. Plasmin is a serine
protease that will degrade all forms of fibrinogen and
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fibrin. The terminal fibrinogen degradation products
are a number of small peptides and two core
fragments, D and E. Fragment D corresponds
roughly to the outer globular domain of fibrinogen,
whereas fragment E contains most of the amino
acids of the central N-terminal-disulphide-knot do-
main. Intermediates in the degradation pathway are
the larger fragments, X and Y (Marder & Bud-
zynski, 1975). The degradation products of non-
cross-linked fibrin are similar to those of fibrinogen,
whereas cross-linked fibrin yields a dimer of frag-
ment D and high-molecular-weight complexes
(Francis et al., 1980a,b). The plasmin degradation
products inhibit coagulation in vivo and gelation of
fibrin in vitro. Such inhibitory activity has been
reported for the intermediate fragments, X and Y
(Marder & Shulman, 1969; Kowalski, 1968), and
also for the core fragments D and D-dimer (Marder
& Shulman, 1969; Kowalski, 1968; Larrieu et al.,
1972; Belitser et al., 1975; Haverkate et al., 1979;
Dray-Attali & Larrieu, 1977; Budzynski et al.,
1979).
In the present paper we describe studies on the
physical properties of fragment D and quanti-
fication of its inhibitory activity. Although plasmin
cleavage of fibrinogen can yield a heterogeneous
family of digestion products (mol.wts. 80000-
100000) owing to multiple sites of y-chain cleavage
(Marder & Budzynski, 1974), we have used the
reported protective effect of calcium (Haverkate &
Timan, 1977) to prepare and isolate a relatively
homogeneous large species of fragment D
(M- 100000). The inhibitory effect of this material
on fibrin formation has been quantified primarily by
measurements of rigidity and light-scattering, which
are sensitive and non-disruptive techniques. The
observation of a prolonged clotting time in the
presence of fragment D could be attributed to any of
the following four possibilities: (1) fragment D could
inhibit thrombin activity, thus blocking gel forma-
tion by interfering with fibrinopeptide release; (2)
fragment D could be incorporated directly into the
gel, resulting in an abnormal clot structure; (3)
fragment D could alter the pattern of assembly
events, resulting in either delayed or abnormal fibre
formation; (4) inhibition of the incorporation of
fibrin monomer into the growing fibrin fibres could
cause the observed effects. The experiments des-
cribed in the present paper have been undertaken
to determine which of these possible modes of
inhibition operates when gelation occurs in the
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Fig. 1. Purification offragment Dfrom a terminalplasmin digest ofhumanfibrinogen
(a) Ultrogel 34 chromatography of a digest of fibrinogen. A 5 ml sample containing 100mg of material was put on a
2.6cm x 100cm column and eluted at 30ml/h. The fraction volume was 4.3 ml. Material eluted after the main peak
had a molecular weight below 30000 and corresponded to fragments A, B, and C. (b) DEAE-cellulose chromato-
graphy of the mixture of fragments D and E from (a). The DEAE-cellulose column (2.5 cm x 30 cm) was equilibrated
with 0.01 M-NaCO3/Na2CO3 buffer, pH8.9. The flow rate was 60ml/h and the fraction volume was 5 ml. A linear
pH/salt gradient with 0.01 M-NaHCO3/Na2CO3/0.3 M-NaCl, pH 8.0, as the limit buffer was used to elute the protein
peaks. The inset shows scans at 570nm from SDS/5%-polyacrylamide-gel electrophoresis of pool D. Relative




Inhibition of fibrin assembly by fragment D
Blomback (1956) (fraction 1-4) was dissolved in
0,3 M-NaCl, centrifuged for 10min at 30000g,
dialysed for 18h to remove free calcium, and then
divided into portions and stored at -700C. Clot-
tability was more than 90 and 97% respectively.
Fibrinogen concentrations were determined from
A280 by using a specific absorption coefficient of
5.27 x 105M-1cm- (Mihalyi, 1968). Plasmin (Kabi)
was reconstituted to 50units/ml with 50% (w/v)
glycerol and stored at -200C. Thrombin was either
of bovine origin (Parke-Davis) or highly purified
human thrombin (lot 88-B, specific activity =
2265 units/mg), which was a gift from Dr. J. W.
Fenton (Fenton et al., 1977). Except where noted,
the thrombin concentration used was 50 units/mg
of fibrinogen. Fibrin-monomer-Sepharose, prepared
as described by Heene & Matthias (1973), was
provided by Dr. N. A. Carrell.
Other reagents were obtained as follows: Tra-
sylol, Mobay Chemical; DEAE-cellulose (DE-52),
Whatman; Ultrogel 34, LKB; Sephadex G-25,
Pharmacia; lactoperoxidase, 70-100units/mg of
protein, Sigma; carrier-free Na125I, Amersham/
Searle; rabbit antisera to human fibrinogen frag-
ment D, Calbiochem-Behring.
All other reagents used were reagent-grade.
Except where noted, buffer used in all physical
experiments was 0.1 M-NaCl/0.05 M-Tris, pH 7.4
(Tris/NaCl).
Methods
Isolation offragment D. Fibrinogen was digested
with plasmin (25 casein units/g of fibrinogen) in the
presence of 2.5 mM-calcium (Haverkate & Timan,
1977) for 13-20h at room temperature. Digestion
was stopped by addition of 75 k.i.u. (kallikrein
inhibitory units) of Trasylol/ml. The digest was put
on a gel-filtration column (Ultrogel 34), which was
equilibrated with 0.3 M-NaCl/0.05 M-Tris, pH 7.4,
to separate fragment Y from fragments D and
E (Fig. 1). Pool 2, containing fragment D (and
E), was dialysed extensively against 0.01 M-bicar-
bonate buffer, pH 8.9. This material was chro-
matographed on DEAE-cellulose essentially as
described by Doolittle et al. (1977). A linear
gradient, from 0.01 M-carbonate, pH 8.9, to 0.01M-
carbonate/0.3M-NaCl, pH 8.0, was used (Fig. 1). In
some cases, fragment D was concentrated on a short
anion-exchange column (2.5cm x 3.0 cm), with
direct elution with the limit buffer and then further
concentrated by dialysis against poly(ethylene gly-
col) 6000. Fragment D was dialysed against
Tris/NaCl directly after chromatography or con-
centration and was used on the same day that it was
isolated. The concentration of fragment D was
determined by its A280, a specific absorption coeffi-
cient of 2.08 x 105M-1. cm-' (Marder et al., 1972)
being used. As polyacrylamide-gel electrophoresis
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reduced 5% gels) has been extensively employed to
characterize the molecular weights of the plasmin
degradation products of fibrinogen (Pizzo et al.,
1972; Haverkate & Timan, 1977), this technique
was employed to establish the identity of the
chromatographed fragments. Non-reduced 59'o-
polyacrylamide Jels.were prepared as described by
McDonagh et<. (1972). Before they were
stained with Coomassie Brilliant Blue, the gels were
fixed with a. solution of 10% (v/v) acetic acid/10%
(v/v) propan-2-ol. The major species of fragment D
used in all experiments had a mol.wt. of
100000 + 10000 (Fig. 1, inset).
Iodination offragment D. Purified fragment D
was labelled with 1251 by the lactoperoxidase
procedure (Kudryk & Blombfick, 1979). Labelled
fragment D was separated from unbound iodine on a
column (1.0cm x 20cm) of Sephadex G-25 and
eluted with 0.15 M-NaCl/0.05 M-Tris, pH 7.4, con-
taining 1% ovalbumin. Radioactivity was measured
in a Beckman Gamma 4000 spectrometer. Anti-
bodies to fragment D were used to determine the
antigenicity of the labelled material, with Staphyl-
ococcus aureus cells as a second precipitant. The
iodinated fragment D precipitated to the extent of
90% with 20% (w/v) trichloroacetic acid, and 79%
with anti-(fragment D) antibodies. Fibrin-monomer-
Sepharose was packed in a 1 ml syringe. A sample of
labelled fragment D was applied to the column, and
the amount of bound label was found to be 63% of
the applied material. SDS/polyacrylamide (reduc-
ing) gels of labelled and unlabelled fragment D were
identical.
Binding offragment D to fibrin and clottability of
fibrinogen
Various amounts of unlabelled D were added to a
constant amount of labelled D and fibrinogen (final
concn. 0.4mg/ml). The A280 was measured before
the addition of thrombin. After 2h the clots were
removed by winding them around glass -rods. The
radioactivity of each clot and supernatant was
measured, and the absorbance of the supernatant
was recorded.
Thrombin assays. A thrombin assay in the
presence of fragment D was performed by Dr. R.
Lundblad. The substrate used was l00pM-ben-
zoylarginine p-nitroanilide in 0.05 M-Tris, pH 8.0.
From 0 to 3.5mg of fragment D were added to
200 units of human a-thrombin (specific activity
3000units/mg), and the final A410nm was moni-
tored.
Fibrinopeptide release was measured by quanti-
fication of the reaction of peptide-bound arginine
with phenanthrenequinone (Yamada & Itano, 1966).
Fibrinogen concentration was constant at 3 mg/ml.
Samples with or without 1.74mg of fragment D/ml
(2mol of fragment D/mol of fibrinogen) were
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incubated at 370C for 0, 1, 3 or 60min with 0.36
units of thrombin/ml or for 60min with 9 units of
thrombin/ml. The fibrinopeptides were separated
and made to react with phenanthrenequinone, and
fluorescence was measured at 395 nm and com-
pared with standard arginine solutions.
Rigidity measurements. The rigidity, or elastic
modulus, of fibrin gels was measured as previously
described (Carr et al., 1976). The fibrinogen
concentration was 0.15mg/ml and the fragment D
concentration ranged from 0 to 0.25 mg/ml. In some
studies, buffer containing 5 mM-CaCl2 was used, and
the fragment D concentration was varied from 0 to
0.12mg/ml. Gelation was achieved by the addition
of thrombin to a final concentration of 1.25 units/ml.
Immediately after the addition of thrombin, the
solution was mixed and poured into the Couette
elastometer and allowed to clot before stress was
applied. Stress was then applied at 5-10min
intervals for less than 30s at a time. Measurements
were made at 250C.
Light-scattering. The apparatus and techniques
for measurement were used as previously described
(Carr et al., 1977; Hantgan & Hermans, 1979).
Buffer and fragment D solutions were degassed and
filtered through presoaked 0.22,um-pore-size Milli-
pore filters in 13mm-diameter Swinnex plastic filter
holders (Millipore). The concentration of fragment
D was determined spectrally after filtration. A small
portion of a concentrated fibrinogen solution was
added to achieve a final fibrinogen concentration of
0.076 mg/ml. Fibrin assembly was initiated by the
addition of a small portion of a concentrated
thrombin solution to a final concentration of
3.8 units/ml. For studies of the angular dependence
of light scattered from inhibited clotting solutions,
fibrinogen concentrations of 0.16 mg/ml and a
thrombin concentration of 3.3 units/ml were em-
ployed. Ratios of 14 to 120 mol of fragment D/mol of
fibrinogen were investigated by angular-dependence
studies, and from 0.5 to 50mol of fragment D/mol
of fibrinogen for 900 intensity studies.
Results
Rigidity measurements
To assay for the inhibitory activity of fragment D
on fibrin clots, the technique of clot rigidity was
used. The data presented in Fig. 2 demonstrate a
tenfold decrease in the elastic modulus of fibres
formed at a ratio of 3 mol of fragment D/mol of
fibrogen. Half maximum inhibition occurs at
about 1 mol of fragment D/mol of fibrinogen,
whereas clots formed under Factor-XIIIa-cross-
linking conditions are even more sensitive to
the presence of fragment D, with half-maxi-
mum inhibition at less than 0.5mol of fragment
D/mol of fibrinogen. SDS/polyacrylamide-gel
electrophoresis of the reduced proteins indicated
0 1 2 3 4 5 6 7
Fragment D (mol/mol)
Fibrinogen
Fig. 2. Clot rigidity at 80min for cross-linked and
non-cross-linked gels as a function of fragment D
concentration
Fibrinogen concentration was constant at 0.15 mg/
ml. 0, Non-cross-linked clots; 0, clots stabilized by
Factor XIIIa and calcium.
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Fig. 3. Percentage ofradiolabelledfragment D that binds
tofibrin gels
Fibrinogen concentration was 0.4mg/ml. The radio-
activity of both the clot and the supernatant was
measured. 0, Non-cross-linked clots; 0, clots
stabilized by Factor XIIIa and calcium.
that 100% of the y-chains and at least 90% of the
a-chains were cross-linked under these conditions.
FragmentD binding tofibrin and clottability
Fragment D radiolabelled with 1251 was employed
to quantify the binding of this fragment to fibrin
fibres. Fig. 3 expresses the results of these experi-
ments as the percentage of fragment D present in
1981
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Table 1. Quantification ofthe distribution offragment D infibrin gels
(a) Shows results for non-cross-linked fibrin, and (b) those for fibrin stabilized by CaCl2















































solution that binds to the resultant fibres, for clots
with and without cross-linking by Factor XIIIa. A
maximum of 10% (15% for cross-linked fibres) of
the radiolabelled material binds at low ratios of
fragment D to fibrinogen. As the molar ratio
increases, the amount of fragment D bound de-
creases by a factor of about 2. Table 1 shows the
increase in the total amount of fragment D bound to
fibrin as the fragment D concentration increases.
There is a linear increase in this parameter, with no
indication of saturation in the accessible range of
fragment D concentrations. Higher ratios of frag-
ment D to fibrinogen inhibit gelation to the extent
that the experiment cannot be performed.
Spectral determinations of the amount of clot-
table protein are listed in Table 1. These results show
a decrease in clottability by a factor of nearly 2 over
this same range of fragment D concentrations. There
is a less pronounced change in clottability in the
presence of calcium and Factor XIIIa.
Light-scattering
Measurements of the intensity of light scattered
from solutions of macromolecules have frequently
been used to determine the size and shape of the
scattering species (Huglin, 1972). In particular,
measurements of the angular dependence of the
intensity of scattered light have been employed to
measure the molecular weight and radius of gyra-
tion of fibrinogen (Hocking et al., 1952), as well as
the size and shape of intermediate polymers formed
in an inhibited clotting system (Ferry, 1952).
Casassa (1955) extended the theory and technique
to measure the mass per unit length of long
oligomers formed after thrombin activation of
fibrinogen at high pH and ionic strength. Carr et al.
(1977) measured the mass/length ratio of both
coarse and fine gels from the angular-dependence of
scattered-light intensity and found the values to
agree well with those determined by solvent-per-
fusion measurements. They verified that, for dilute
gels, the intensity of scattered light [R(a)I is
inversely proportional to sin (0/2), in which is the
angle between the primary and scattered beam. Thus
measurement of the scattered-light intensity at a
single angle of 900 can be used to determine the
mass/length ratio of fibrin fibres. The scattering
intensity is determined relative to the scattering of
benzene, for which the absolute scattering has been
accurately determined (Pike et al., 1975). The
following equations apply:
and




where c is the concentration, K is an optical
constant, n is the refractive index, AO the wavelength
in vacuo, N is Avogadro's number and p is the
mass/length ratio.
Measurements of light-scattering intensity were
used to examine the characteristics of the fibres
formed in the presence of fragment D (Fig. 4). The
mass/length ratio, determined from the 900 scatter,
ing intensity, was found to increase from the control
value of 60 molecules/cross-section to 120 mole-
cules/cross-section at a fragment D concentration
corresponding to 2mol of fragment D/mol of
fibrinogen. Higher fragment D concentrations lead
to a decrease in final fibre thickness. Beyond 15 mol
of fragment D/mol of fibrinogen, no clot is observed
after 1 h, and the final fibre thickness corresponds to
thin fibres with a width less than twice that of the
protofibril. Cross-linked and non-cross-linked clots
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Fragment D
Fibrinogen
Fig. 4. Average fibre thickness as measured by light-
scattering with increasingfragment D concentrations
Fibrinogen concentration: 0.076 mg/ml in 0.1 M-
NaCl/0.05 M-Tris, pH 7.4. 0, Non-cross-linked
clots; 0, clots stabilized by Factor XIIIa and
calcium.
higher fibrinogen and fragment D concentrations,
measurements of the angular dependence of the
intensity of scattered light indicated that short
oligomers resulted from thrombin activation. (This
technique yielded molecular weights of
33000010+000 and 105000+18000 for fibrino-
gen and fragment D respectively.) The data in Table
2 demonstrate that raising the fragment D con-
centration causes a decrease in the molecular weight
and length of the scattering species. The length of
these oligomers decreases from 270 to 85 nm over
the range of fragment D concentrations investi-
gated. At lower fragment D/fibrinogen ratios,
gelation results and the length of the fibres cannot be
determined by this light-scattering technique.
The measured oligomer dimensions are com-
pared in Table 2 with those calculated for proto-
fibrils, formed by a half-staggered overlap of
activated fibrinogen molecules (Ferry, 1952; Hant-
gan et al., 1980). Molecular dimensions of fibrino-
gen determined by electron microscopy (Fowler &
Erickson, 1979) were used in calculations. The
results obtained indicate that, at 14.4 mol of frag-



























ment D/mol of fibrinogen, protofibrils consisting of
nine + one monomers are formed, whereas at ratios
of 120mol of fragment D/mol of fibrinogen, a
polymer length corresponding to that of a trimer of
activated fibrinogen molecules results. Viscosity
measurements also show that protofibril length
decreases with increasing concentrations of frag-
ment D.
Thrombin activity
Thrombin-activity assays, which monitor the
hydrolysis of the synthetic substrate benzoylarginine
p-nitroanilide, indicated that thrombin retains 90% of
its activity at ratios of 15 mol of fragment D/mol of
thrombin and 75% of its initial activity at a 20-fold
excess of fragment D. The fibrinopeptide release
assay showed no difference in the rate or of the final
number of fibrinopeptides released from fibrinogen
in the presence of 100-fold molar excess of fragment
D to thrombin. This lack of significant thrombin
inhibition is important to an interpretation of the
physical-chemical studies of the mode of inhibition
of fragment D.
Discussion
Previous studies of the anticoagulant activity of
fragment D have emphasized the decreased fibrino-
gen clottability (Kowalski, 1968) and the prolonged
thrombin clotting time in the presence of fragment D
(Marder & Shulman, 1969; Kowalski, 1968; Larrieu
et al., 1972; Belitser et al., 1975; Haverkate et al.,
1979). In the present paper we report further
characterization of the inhibitory properties of
fragment D based on measurements of the physical
properties of the fibrin formed in the presence of
fragment D.
Antithrombin activity
Until now, purified fragment D has not been
assayed directly for its effect on the enzymic activity
of thrombin; however, the following observations
have been made. Alkjaersig et al. (1962) noted that
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the benzoylarginine methylesterase assay for throm-
bin was unaffected by a mixture of fibrinogen
proteolysis products, whereas Latallo et al. (1964)
showed that late degradation products (mainly
fragments D and E) had little or no effect on total
fibrinopeptide release as measured by trichloro-
acetic acid-soluble peptides. These results are con-
sistent with the data presented here, in which the use
of a chromogenic substrate for thrombin showed the
lack of significant inhibition at less than 20mol of
fragment D/mol of thrombin. We have also shown
that fragment D does not affect either the rate or
total release of fibrinopeptides. Also, Belitser et al.
(1975) found that polymerization of preformed fibrin
monomer was strongly inhibited by a late plasmin
digest of fibrinogen formed in the presence of
calcium, and thereby demonstrated that inhibition of
thrombin, if any, is not a requirement for the
inhibition of assembly. In summary, inhibition of
polymerization by fragment D cannot be due to
inhibition of thrombin activity.
Clot rigidity
The elastic modulus of fibrin fibres depends on the
square of the fibrinogen concentration, the fibre
thickness, the number of network branchpoints and
the bulk rigidity of the fibres, and can be altered by
changes in calcium concentration, ionic strength,
and Factor XIIIa cross-linking (Shen et al., 1975;
Nelb et al., 1976). It has been previously reported
that plasmin degradation of fibrin(ogen) leads to a
decreased clot rigidity (Shen et al., 1977); the results
presented here demonstrate that the purified plasmin
degradation product, fragment D, can inhibit the
development of the elastic modulus of fibrin fibres.
As the binding of fragment D to fibrin shows no
evidence of saturation, we can conclude that a large
number of potential binding sites for fragment D are
present on fibrin; but this inhibitory effect occurs
under conditions where only small amounts of
fragment D actually bind to the fibres (< 10% of the
fragment D in solution). Therefore we can rule out
the explanation that the bound fragment D inter-
feres with gelation by altering the structure of the
fibrin formed. For example, at 1.4mol of fragment
D/mol of fibrinogen, less than 4% of the fragment D
in solution binds to fibrin; there is a fourfold
decrease in the elastic modulus, but there is also a
twofold decrease in the amount of clottable protein.
As the elastic modulus is proportional to the square
of the fibrinogen concentration, this decrease in clot
rigidity should be directly attributed to a decrease in
the amount of clottable protein rather than to
alterations in fibrin structure. That is, the binding,
clot-rigidity and clottability data all indicate that the
protein which clots in the presence of fragment D
forms normal fibrin, and that the remainder of the
protein is apparently blocked from entering the gel
by the presence of fragment D.
Fibreformation
The results presented here demonstrate that
fragment D, at concentrations of more than 2 mol of
fragment D/mol of fibrinogen, inhibits fibre forma-
tion. Above 14mol of fragment D/mol of fibrino-
gen, gelation is fully blocked. The data in Table 2
demonstrate that the molecular weight and length of
the resulting short oligomers correspond to proto-
fibrils composed of three to nine monomers, ar-
ranged in the half-staggered overlap structure. These
observations suggest that fragment D may interfere
with fibrin assembly by directly blocking the first
assembly step, namely the bimolecular polymeriza-
tion of activated fibrin monomer molecules to form
protofibrils. Inhibition of this first assembly event
would be observed at all subsequent stages of the
gelation process. Therefore the observations of
decreased clottability, decreased elastic modulus and
the presence of short oligomers in solution, which
characterize fibrin formation in the presence of
fragment D, can all be explained by a mechanism in
which fragment D binds to the growing protofibrils,
thus stopping the incorporation of fibrin monomer
into these two stranded polymers, which are obliga-
tory intermediates in the fibrin-assembly pathway.
It has already been shown that fragment D
contains a polymerization site, because it interacts
with fibrin-monomer-Sepharose (Kudryk et al.,
1973; Matthias et al., 1973; York & Blombaick,
1976; Heene et al., 1979; Olexa & Budzynski, 1980)
and thrombin activated N-terminal disulphide knot
covalently linked to Sepharose (Kudryk et al.,
1974). The D-domain in fibrin monomer can form
stable contacts with both the E- and D-domains of
fibrin fibres (Hermans, 1979). Fragment D may also
compete for this site, consequently blocking proto-
fibril growth by forming a 'dead-end' complex that
cannot undergo further bimolecular addition of the
next fibrin monomer molecule. It is clear, however,
that small amounts of fragment D, less than
1 mol/mol of fibrinogen, are sufficient to produce
substantially weaker clots.
We thank Dr. R. Doolittle and Dr. B. Kudryk for
providing protocols of fragment D separation and
radiolabelling, Dr. J. Fenton for kindly giving a-throm-
bin, Dr. N. Carrell for fibrin-monomer-Sepharose, and
Dr. R. Lundblad for performing thrombin assays. This
work was supported by National Institutes of Health
grants nos. HL20319, HL22505 and HL21139. J. M. is
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Association.
References
Alkjaersig, N., Fletcher, A. P. & Sherry, S. (1962) J. Clin.
Invest. 41, 917-934
Vol. 197
668 J. E. Williams, R. R. Hantgan, J. Hermans and J. McDonagh
Belitser, V. A., Varetska, T. V., Tolstykh, V. M., Tsaryuk,
L. A. & Pozdnyakova, T. M. (1975) Thromb. Res. 7,
797-806
Bettelheim, F. R. (1956) Biochim. Biophys. Acta 19,
121-130
Blomback, B. (1958)Ark. Kemi 12, 321-335
Blomback, B. & Blombiick, M. (1956) Ark. Kemi 10,
415-443
Blomback, B., Hessel, B., Hogg, D. & Therkildsen, L.
(1978) Nature (London) 275, 501-505
Budzynski, A. Z., Olexa, S. A. & Brizuela, B. S. (1979)
Biochim. Biophys. Acta 584, 284-287
Carr, M. E., Shen, L. L. & Hermans, J. (1976) Anal.
Biochem. 72, 202-211
Carr, M. E., Shen, L. L. & Hermans, J. (1977)
Biopolymers 16, 1-15
Casassa, E. F. (1955) J. Chem. Phys. 23, 596-597
Doolittle, R. F. (1977) Horiz. Biochem. Biophys. 3,
164-191
Doolittle, R. F., Cassman, K. G., Cottrell, B. A., Friezner,
S. J. & Takagi, T. (1977) Biochemistry 16, 1710-1715
Dray-Attali, L. & Larrieu, M. J. (1977) Thromb. Res. 10,
575-586
Fenton, J. W., Landis, B. H., Walz, D. A. & Finlayson,
J. S. (1977) in Chemistry and Biology of Thrombin
(Lundblad, R. L., Fenton, J. W. & Mann, K. G., eds.),
pp. 43-70, Ann Arbor Science Publishers, Ann Arbor,
MI
Ferry, J. D. (1952) Proc. Natl. Acad. Sci. U.S.A. 38,
566-569
Fowler, W. E. & Erickson, H. P. (1979) J. Mol. Biol. 134,
241-249
Francis, C. W., Marder, V. J. & Barlow, G. H. (1980a) J.
Clin. Invest. 66, 1033-1043
Francis, C. W., Marder, V. J. & Martin, S. E. (1980b)
Blood 36,456-464
Hall, C. E. & Slayter, H. S. (1959) J. Biophys. Biochem.
Cytol. 5, 11-16
Hantgan, R. R. & Hermans, J. (1979) J. Biol. Chem. 254,
11272-11281
Hantgan, R., Fowler, W., Erickson, H. & Hermans, J.
(1980) Thromb. Haemostasis 44, 119-124
Haverkate, F. & Timan, G. (1977) Thromb. Res. 10,
803-812
Haverkate, F., Timan, G. & Nieuwenhuizen, W. (1979)
Eur. J. Clin. Invest. 9, 253-255
Heene, D. L. & Matthias, F. R. (1973) Thromb. Res. 2,
137-154
Heene, D. L., Matthias, F. R., Wegrzynowicz, Z. &
Hocke, G. (1979) Thromb. Haemostasis 41, 677-686
Hermans, J. (1979) Proc. Natl. Acad. Sci. U.S.A. 76,
1189-1193
Hocking, C. S., Laskowski, M., Jr. & Scheraga, H. A.
(1952) J. Am. Chem. Soc. 74, 775-778
Huglin, M. B. (ed.) (1972) Light Scatteringfrom Polymer
Solutions, Academic Press, New York
Kowalski, E. (1968) Semin. Hematol. 5,45-59
Kudryk, B. & Blombiick, M. (1979) Thromb.
Haemostasis 42, 120
Kudryk, B., Reuterby, J. & Blomback, B. (1973) Thromb.
Res. 2, 297-304
Kudryk, B., Collen, D., Woods, K. R. & Blomback, B.
(1974) J. Biol. Chem. 249, 3322-3325
Larrieu, M. J., Riggollot, C. & Marder, V. J. (1972) Br. J.
Haematol. 22, 719-733
Latallo, Z. S., Budzynski, A. Z., Lipinski, B. & Kowalski,
E. (1964) Nature (London) 203, 1184-1185
Marder, V. J. & Budzynski, A. Z. (1974) Prog.
Haemostasis Thromb. 2, 141-174
Marder, V. J. & Budzynski, A. Z. (1975) Thromb. Diath.
Haemorrh. 33, 199-207
Marder, V. J. & Shulman, N. R. (1969) J. Biol. Chem.
244, 2120-2124
Marder, V. J., Budzynski, A. Z. & James, H. L. (1972) J.
Biol. Chem. 247,4775-4781
Matthias, F. R., Heene, D. L. & Konradi, E. (1973)
Thromb. Res. 3, 657-664
McDonagh, J., Messel, H., McDonagh, R. P., Murano,
G. & Blomback, B. (1972) Biochim. Biophys. Acta
257, 135-142
Mihalyi, E. (1968) Biochemistry 7, 208-223
Nelb, G. W., Gerth, C., Ferry, J. D. & Lorand, L. (1976)
Biophys. Chem. 5, 377-387
Olexa, S. A. & Budzynski, A. Z. (1980) Proc. Natl. Acad.
Sci. U.S.A. 77, 1374-1378
Pike, E. R., Romeroy, W. R. M. & Vaughan, J. M. (1975)
J. Chem. Phys. 62, 3188-3192
Pizzo, S. V., Schwartz, M. L., Hill, R. L. & McKee, P. A.
(1972) J. Biol. Chem. 247, 636-645
Shen, L. L., Hermans, J., McDonagh, J., McDonagh,
R. P. & Carr, M. (1975) Thromb. Res. 6, 255-
265
Shen, L. L., McDonagh, R. P., McDonagh, J. &
Hermans, J. (1977) J. Biol. Chem. 252,6184-6189
Weisel, J. W., Phillips, G. N. & Cohen, C. (1981) Nature
(London) 289, 263-267
Yamada, S. & Itano, H. A. (1966) Biochim. Biophys.
Acta 130,538-540
York, L. L. & Blomback, B. (1976) Thromb. Res. 8,
607-618
1981
